Search Results

Site Search

Six ways innovative lupus tests are transforming patient and clinician experiences - Insights

The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus. Yet, the most widely used laboratory tests for patients with this complex condition were developed more than 60 years ago, and...

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services - Insights

Mayo Clinic Laboratories and Lucence are expanding access to advanced cancer testing worldwide with LiquidHALLMARK®, a next-generation liquid biopsy that provides actionable genomic insights. This collaboration empowers physicians to...

Hereditary neuromuscular disorders - Insights

Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.

Solutions for Common Service Recovery Challenges - Insights

Despite our best efforts, customer service failures do happen, but good service recovery tools can turn failures into positive customer experiences.

Three core elements of exceptional customer service - Insights

Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.

Managing Compliance in Preparation for 2025 Updates - Insights

With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans.

B-cell and T-cell acute lymphoblastic leukemia - Insights

Find out how our suite of B-cell and T-cell acute lymphoblastic leukemia tests can detect genetic subgroups and assist in treatment selection.

VEXAS syndrome - Insights

Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.

Is the term "outreach" obsolete? - Insights

In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...

Preparing a customer performance update report - Insights

Depending on the types of specimens that are referred to the outreach laboratory, there may be an opportunity to share a customer performance update report with the client so that they can align with, or even develop their own laboratory...